Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 1
2007 3
2008 5
2009 6
2010 2
2011 1
2012 2
2013 4
2015 8
2016 3
2017 14
2018 3
2019 12
2020 4
2021 4
2022 9
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.
COVID-19 and Lipid Disorders.
Julius U, Schatz U, Tselmin S, Morawietz H. Julius U, et al. Horm Metab Res. 2022 Aug;54(8):514-521. doi: 10.1055/a-1860-2610. Epub 2022 Jul 14. Horm Metab Res. 2022. PMID: 35835148 Review.
COVID-19 and Therapeutic Apheresis.
Tselmin S, Julius U, Jarzebska N, Rodionov RN. Tselmin S, et al. Among authors: julius u. Horm Metab Res. 2022 Aug;54(8):571-577. doi: 10.1055/a-1864-9482. Epub 2022 Aug 9. Horm Metab Res. 2022. PMID: 35944525
[State of the art: lipoprotein apheresis].
Schatz U, Schettler VJJ, Julius U. Schatz U, et al. Among authors: julius u. Dtsch Med Wochenschr. 2023 Apr;148(8):e44-e54. doi: 10.1055/a-1516-2761. Epub 2023 Mar 29. Dtsch Med Wochenschr. 2023. PMID: 36990113 Free PMC article. Review. German.
History of lipidology and lipoprotein apheresis.
Julius U. Julius U. Atheroscler Suppl. 2017 Nov;30:1-8. doi: 10.1016/j.atherosclerosissup.2017.05.034. Epub 2017 Jun 1. Atheroscler Suppl. 2017. PMID: 29096824 Review.
Niacin as antidyslipidemic drug.
Julius U. Julius U. Can J Physiol Pharmacol. 2015 Dec;93(12):1043-54. doi: 10.1139/cjpp-2014-0478. Epub 2015 Apr 28. Can J Physiol Pharmacol. 2015. PMID: 26370906 Review.
Correction: COVID-19 and Therapeutic Apheresis.
Tselmin S, Julius U, Jarzebska N, Rodionov RN. Tselmin S, et al. Among authors: julius u. Horm Metab Res. 2022 Aug;54(8):e5. doi: 10.1055/a-1930-9384. Epub 2022 Sep 2. Horm Metab Res. 2022. PMID: 36055341 No abstract available.
Management of patients with statin intolerance.
Fischer S, Julius U. Fischer S, et al. Among authors: julius u. Atheroscler Suppl. 2017 Nov;30:33-37. doi: 10.1016/j.atherosclerosissup.2017.05.013. Epub 2017 Jun 1. Atheroscler Suppl. 2017. PMID: 29096858 Review.
The German CaRe high registry for familial hypercholesterolemia - Sex differences, treatment strategies, and target value attainment.
März W, Schmidt N, An Haack I, Dressel A, Grammer TB, Kleber ME, Baessler A, Beil FU, Gouni-Berthold I, Julius U, Kassner U, Katzmann JL, Klose G, König C, Koenig W, Koschker AC, Laufs U, Merkel M, Otte B, Parhofer KG, Hengstenberg W, Schunkert H, Stach-Jablonski K, Steinhagen-Thiessen E, Olivier CB, Hahmann H, Krzossok S, Vogt A, Müller-Wieland D, Schatz U. März W, et al. Among authors: julius u. Atheroscler Plus. 2023 Jun 12;53:6-15. doi: 10.1016/j.athplu.2023.06.001. eCollection 2023 Sep. Atheroscler Plus. 2023. PMID: 37434912 Free PMC article. Review.
80 results